Dr. Andrew Davis, M.D.
Claim this profileWashington University School of Medicine
Studies Breast Cancer
Studies Breast cancer
8 reported clinical trials
21 drugs studied
Area of expertise
1Breast Cancer
HER2 negative
Stage IV
Stage II
2Breast Cancer
Stage I
Stage II
Stage III
Affiliated Hospitals
Clinical Trials Andrew Davis, M.D. is currently running
TAB004 + Toripalimab
for Solid Cancers
The primary objective is to assess the safety and tolerability of TAB004 as monotherapy and in combination with toripalimab in subjects with selected advanced solid malignancies, including lymphoma, and to evaluate the recommended Phase 2 dose. The secondary objectives are to: 1) describe the pharmacokinetic (PK) profile of TAB004 monotherapy and in combination with toripalimab and to describe the PK profile of toripalimab when administered with TAB004, 2) evaluate antitumor activity of TAB004 monotherapy and in combination with toripalimab; and 3) determine the immunogenicity of TAB004 monotherapy and in combination with toripalimab and to determine the immunogenicity of toripalimab when administered with TAB004. The exploratory objectives are to: 1) evaluate pharmacodynamic effects of TAB004 on its target receptor BTLA, as well as effects on the immune system; 2) evaluate biomarkers that may correlate with activity of TAB004 as monotherapy and in combination with toripalimab; 3) evaluate the utility of BTLA ligand, herpesvirus-entry mediator (HVEM), and additional exploratory biomarkers that could aid in selection of appropriate subjects for TAB004 monotherapy and in combination with toripalimab.
Recruiting1 award Phase 110 criteria
Zunsemetinib + Capecitabine
for Breast Cancer
This is a phase Ib/II study evaluating the safety and efficacy of zunsemetinib (ATI-450) with capecitabine in patients with hormone receptor-positive and HER2-negative (HR+/HER2-) metastatic breast cancer (MBC).
Recruiting1 award Phase 1 & 26 criteria
More about Andrew Davis, M.D.
Clinical Trial Related6 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Andrew Davis, M.D. has experience with
- Paclitaxel
- Fulvestrant
- Blood Draw
- Bone Marrow
- Carboplatin
- Nivolumab
Breakdown of trials Andrew Davis, M.D. has run
Breast Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Davis, M.D. specialize in?
Andrew Davis, M.D. focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 negative patients, or patients who are Stage IV.
Is Andrew Davis, M.D. currently recruiting for clinical trials?
Yes, Andrew Davis, M.D. is currently recruiting for 5 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Andrew Davis, M.D. has studied deeply?
Yes, Andrew Davis, M.D. has studied treatments such as Paclitaxel, Fulvestrant, Blood draw.
What is the best way to schedule an appointment with Andrew Davis, M.D.?
Apply for one of the trials that Andrew Davis, M.D. is conducting.
What is the office address of Andrew Davis, M.D.?
The office of Andrew Davis, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.